HR 5605 · 115th Congress 2017–2019, ended

Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act

Latest action · Jun 20, 2018 Received in the Senate and Read twice and referred to the Committee on Finance.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 24, 2018
  2. Passed HouseJun 19, 2018
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act

(Sec. 2) This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration program to: (1) increase access to opioid-use disorder treatment services for Medicare beneficiaries, (2) improve physical and mental health outcomes for such beneficiaries, and (3) reduce Medicare expenditures.

Opioid-use disorder care teams of practitioners may apply for participation in the demonstration project. The CMS must establish a performance-based incentive payment for participants.

(Sec. 3) The bill also requires prescriptions for controlled substances that are covered under the Medicare prescription drug benefit or Medicare Advantage prescription drug plans to be transmitted via electronic prescription programs. The CMS may waive such requirements under specified circumstances.

Cosponsors 2

Members who signed on, in the order they did. All signed on May 24, 2018.

SeatCosponsorSigned on
R-ORGreg WaldenMay 24, 2018
R-TNMarsha BlackburnMay 24, 2018

Committees 3

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Apr 24, 2018Markup May 17, 2018Reported Jun 12, 2018
HouseWays and Means Committee
Referred Apr 24, 2018Discharged Jun 12, 2018
Health Subcommittee
Referred May 1, 2018
SenateFinance Committee
Referred Jun 20, 2018

Actions 15

Everything that happened, newest first.

  1. Jun 20, 2018Received in the Senate and Read twice and referred to the Committee on Finance.
  2. Jun 19, 2018Mr. Walden moved to suspend the rules and pass the bill, as amended.
  3. Jun 19, 2018Considered under suspension of the rules. (consideration: CR H5239-5243)
  4. Jun 19, 2018DEBATE - The House proceeded with forty minutes of debate on H.R. 5605.
  5. Jun 19, 2018Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5239-5241)
  6. Jun 19, 2018Motion to reconsider laid on the table Agreed to without objection.
  7. Jun 19, 2018The title of the measure was amended. Agreed to without objection.
  8. Jun 12, 2018Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-744, Part I.
  9. Jun 12, 2018Committee on Ways and Means discharged.
  10. Jun 12, 2018Placed on the Union Calendar, Calendar No. 578.
  11. May 17, 2018Committee Consideration and Mark-up Session Held.
  12. May 17, 2018Ordered to be Reported (Amended) by Voice Vote.
  13. May 1, 2018Referred to the Subcommittee on Health.
  14. Apr 24, 2018Introduced in House
  15. Apr 24, 2018Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H5239–H5243Text printed H5239–H5241Greg Walden R-OR, Joseph P. Kennedy III D-MA, Raul Ruiz D-CA, Sheila Jackson Lee D-TXJun 19, 2018

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Congressional Budget Office cost estimate

  1. Jun 11, 2018H.R. 5605, Advancing High Quality Treatment for Opioid Use Disorders in Medicare ActAs ordered reported by the House Committee on Energy and Commerce on May 17, 2018

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, section 8, Clauses 1 and 18 of the United States Constitution, to provide for the general welfare and make all laws necessary and proper to carry out the powers of Congress.

The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 66, April 24, 2018, page H3506.

Related bills 3

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 6SUPPORT for Patients and Communities ActRelated billOct 24, 2018
S 2460Every Prescription Conveyed Securely ActRelated billFeb 27, 2018
HR 3528Every Prescription Conveyed Securely ActRelated billJun 12, 2018

Titles 5

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XVIII of the Social Security Act to provide for an opioid use disorder treatment demonstration program.
Official Titles as Amended by House
To amend title XVIII of the Social Security Act to provide for an opioid use disorder treatment demonstration program, and for other purposes.
Short Titles as Introduced
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
Short Titles as Reported to House
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
Short Titles as Passed House
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 4

Each version as it was printed, newest first.

  1. Jun 20, 2018Referred in Senate
  2. Jun 19, 2018Engrossed in House
  3. Jun 12, 2018Reported in House
  4. Apr 24, 2018Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.